Matthias Theobald

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Eric L. Sievers, Richard A. Larson, Edward A. Stadtmauer et al. · Journal of Clinical Oncology · 2001 · 893 citations

Medicine, Hematology, Pharmacology +17

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

Medicine, Hematology, Oncology +17

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

Richard A. Larson, Eric L. Sievers, Edward A. Stadtmauer et al. · Cancer · 2005 · 458 citations

Medicine, Hematology, Pharmacology +17

Cytarabine Dose for Acute Myeloid Leukemia

Bob Löwenberg, Thomas Pabst, Edo Vellenga et al. · New England Journal of Medicine · 2011 · 407 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

Bob Löwenberg, Wim van Putten, Matthias Theobald et al. · New England Journal of Medicine · 2003 · 384 citations · Full text

Medicine, Hematology, Oncology +16